IP Library Granted Patent US 11,174,252
Granted Patent B2
US 11,174,252 · App. 16/277,355 · Granted Nov 16, 2021

Heterocyclic compounds as kinase inhibitors

Inventors: Son Minh Pham (San Francisco, CA); Sarvajit Chakravarty (Edmond, OK); Jayakanth Kankanala (St. Paul, MN); Brahmam Pujala (Greater Noida, IN); Amit Shete (Noida, IN); Bhawana Bhatt (Greater Noida, IN); Anil Kumar Agarwal (Noida, IN); Sanjeev Soni (Noida, IN); Jiyun Chen (Moraga, CA)
Assignee: NUVATION BIO INC.
C07D413/14A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,174,252
App. No.
16/277,355
Granted
Nov 16, 2021
Kind
B2
Abstract

Heterocyclic compounds of Formula (J) as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Claims (106)

1. A compound, or pharmaceutically acceptable a salt thereof, wherein the compound is selected from the group consisting of

2. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

3. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

4. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

5. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

6. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

7. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

8. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

9. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

10. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

11. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

12. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

13. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

14. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

15. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

16. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

17. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

18. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

19. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

20. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

21. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

22. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

23. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

24. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

25. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

26. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

27. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

28. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

29. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is

30. The compound of claim 6 , wherein the compound is

31. The compound of claim 7 , wherein the compound is

32. The compound of claim 8 , wherein the compound is

33. The compound of claim 9 , wherein the compound is

34. The compound of claim 10 , wherein the compound is

35. The compound of claim 11 , wherein the compound is

36. The compound of claim 12 , wherein the compound is

37. The compound of claim 13 , wherein the compound is

38. The compound of claim 19 , wherein the compound is

39. The compound of claim 15 , wherein the compound is

40. The compound of claim 16 , wherein the compound is

41. The compound of claim 17 , wherein the compound is

42. The compound of claim 18 , wherein the compound is

43. The compound of claim 19 , wherein the compound is

44. The compound of claim 20 , wherein the compound is

45. The compound of claim 21 , wherein the compound is

46. The compound of claim 22 , wherein the compound is

47. The compound of claim 23 , wherein the compound is

48. The compound of claim 24 , wherein the compound is

49. The compound of claim 25 , wherein the compound is

50. The compound of claim 26 , wherein the compound is

51. The compound of claim 27 , wherein the compound is

52. The compound of claim 28 , wherein the compound is

53. The compound of claim 29 , wherein the compound is

54. A pharmaceutical composition comprising a compound of claim 1 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

55. A pharmaceutical composition comprising a compound of claim 2 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

56. A pharmaceutical composition comprising a compound of claim 3 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

57. A pharmaceutical composition comprising a compound of claim 4 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

58. A pharmaceutical composition comprising a compound of claim 5 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

59. A pharmaceutical composition comprising a compound of claim 6 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

60. A pharmaceutical composition comprising a compound of claim 7 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

61. A pharmaceutical composition comprising a compound of claim 8 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

62. A pharmaceutical composition comprising a compound of claim 9 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

63. A pharmaceutical composition comprising a compound of claim 10 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

64. A pharmaceutical composition comprising a compound of claim 11 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

65. A pharmaceutical composition comprising a compound of claim 12 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

66. A pharmaceutical composition comprising a compound of claim 13 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

67. A pharmaceutical composition comprising a compound of claim 14 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

68. A pharmaceutical composition comprising a compound of claim 15 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

69. A pharmaceutical composition comprising a compound of claim 16 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

70. A pharmaceutical composition comprising a compound of claim 17 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

71. A pharmaceutical composition comprising a compound of claim 18 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

72. A pharmaceutical composition comprising a compound of claim 19 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

73. A pharmaceutical composition comprising a compound of claim 20 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

74. A pharmaceutical composition comprising a compound of claim 21 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

75. A pharmaceutical composition comprising a compound of claim 22 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

76. A pharmaceutical composition comprising a compound of claim 23 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

77. A pharmaceutical composition comprising a compound of claim 24 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

78. A pharmaceutical composition comprising a compound of claim 25 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

79. A pharmaceutical composition comprising a compound of claim 26 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

80. A pharmaceutical composition comprising a compound of claim 27 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

81. A pharmaceutical composition comprising a compound of claim 28 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

82. A pharmaceutical composition comprising a compound of claim 29 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

83. A pharmaceutical composition comprising a compound of claim 30 and a pharmaceutically acceptable carrier.

84. A pharmaceutical composition comprising a compound of claim 31 and a pharmaceutically acceptable carrier.

85. A pharmaceutical composition comprising a compound of claim 32 and a pharmaceutically acceptable carrier.

86. A pharmaceutical composition comprising a compound of claim 33 and a pharmaceutically acceptable carrier.

87. A pharmaceutical composition comprising a compound of claim 34 and a pharmaceutically acceptable carrier.

88. A pharmaceutical composition comprising a compound of claim 35 and a pharmaceutically acceptable carrier.

89. A pharmaceutical composition comprising a compound of claim 36 and a pharmaceutically acceptable carrier.

90. A pharmaceutical composition comprising a compound of claim 37 and a pharmaceutically acceptable carrier.

91. A pharmaceutical composition comprising a compound of claim 38 and a pharmaceutically acceptable carrier.

92. A pharmaceutical composition comprising a compound of claim 39 and a pharmaceutically acceptable carrier.

93. A pharmaceutical composition comprising a compound of claim 40 and a pharmaceutically acceptable carrier.

94. A pharmaceutical composition comprising a compound of claim 41 and a pharmaceutically acceptable carrier.

95. A pharmaceutical composition comprising a compound of claim 42 and a pharmaceutically acceptable carrier.

96. A pharmaceutical composition comprising a compound of claim 43 and a pharmaceutically acceptable carrier.

97. A pharmaceutical composition comprising a compound of claim 44 and a pharmaceutically acceptable carrier.

98. A pharmaceutical composition comprising a compound of claim 45 and a pharmaceutically acceptable carrier.

99. A pharmaceutical composition comprising a compound of claim 46 and a pharmaceutically acceptable carrier.

100. A pharmaceutical composition comprising a compound of claim 47 and a pharmaceutically acceptable carrier.

101. A pharmaceutical composition comprising a compound of claim 48 and a pharmaceutically acceptable carrier.

102. A pharmaceutical composition comprising a compound of claim 49 and a pharmaceutically acceptable carrier.

103. A pharmaceutical composition comprising a compound of claim 50 and a pharmaceutically acceptable carrier.

104. A pharmaceutical composition comprising a compound of claim 51 and a pharmaceutically acceptable carrier.

105. A pharmaceutical composition comprising a compound of claim 52 and a pharmaceutically acceptable carrier.

106. A pharmaceutical composition comprising a compound of claim 53 and a pharmaceutically acceptable carrier.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2026
From: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
To: NUVATION BIO INC.
Reel/Frame 075179/0564 →
SECURITY INTEREST Recorded Mar 4, 2025
From: NUVATION BIO INC.
To: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
Reel/Frame 070400/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: PHAM, SON MINH; CHAKRAVARTY, SARVAJIT; KANKANALA, JAYAKANTH; CHEN, JIYUN
To: SPARCBIO LLC
Reel/Frame 052285/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: PUJALA, BRAHMAM; SHETE, AMIT; BHATT, BHAWANA; AGARWAL, ANIL KUMAR; SONI, SANJEEV
To: INTEGRAL BIOSCIENCES PVT. LTD.
Reel/Frame 052285/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: GIRAFPHARMA LLC
To: NUVATION BIO INC.
Reel/Frame 052285/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: SPARCBIO LLC
To: GIRAFPHARMA LLC
Reel/Frame 052285/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2020
From: INTEGRAL BIOSCIENCES PVT. LTD.
To: GIRAFPHARMA LLC
Reel/Frame 052285/0336 →
Continuity (2)
Provisional Application 62631437 · Feb 15, 2018
Related Publication 20190248774A1 · Aug 15, 2019